2017
DOI: 10.1016/j.spinee.2017.01.012
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy comparison of Accell Evo3 and Grafton demineralized bone matrix putties against autologous bone in a rat posterolateral spine fusion model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
7
0

Year Published

2020
2020
2025
2025

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(8 citation statements)
references
References 21 publications
1
7
0
Order By: Relevance
“…Several animal/human cohort studies recognized no significant differences between the performance of allografts and autografts 20–22 . Commercial demineralized bone matrix (DBM) allografts, such as Accell Evo3® and Grafton® exhibited higher rates of posterolateral spinal fusion than iliac crest autografts in a rat study 23 . Similar observations were found in a sheep study 24 .…”
Section: Classificationmentioning
confidence: 70%
See 1 more Smart Citation
“…Several animal/human cohort studies recognized no significant differences between the performance of allografts and autografts 20–22 . Commercial demineralized bone matrix (DBM) allografts, such as Accell Evo3® and Grafton® exhibited higher rates of posterolateral spinal fusion than iliac crest autografts in a rat study 23 . Similar observations were found in a sheep study 24 .…”
Section: Classificationmentioning
confidence: 70%
“…The differences in the outcomes of studies using similar materials could be due to the different animal models used, the various treatment sites, the sample sizes, expertise, and techniques used for observations (histological stains used and the use of micro‐CT, etc.). Accell®, Evo3®, and Grafton® also performed better than autografts in a spinal fusion study 23 . Other scaffolds such as ArcGel®, 158 mPEG/PLGA hydrogel with BMP‐2, 56 HCCP polymer, 57 Bio‐Oss®, 58 zirconia/HAp composites, 54 and porous HAp scaffolds 81 behaved similarly to autografts in the animal models.…”
Section: Discussionmentioning
confidence: 89%
“…Rats are lower cost, facilitate shorter operation times and higherthroughput studies, and most importantly, enable more in-depth analyses of the biology underlying fusion due to a wider availability of cellular and molecular tools. Various fusion therapies have been studied in rat models, including: a range of bone graft substitute and extension materials; systemic and localized delivery of osteogenic growth factors and/or osteoporosis therapies; and, stem cell transplantation therapies [4][5][6][7][8][9][10][11][12][13][14].…”
Section: Introductionmentioning
confidence: 99%
“…Rats are lower cost, facilitate shorter operation times and higher-throughput studies, and most importantly, enable more in-depth analyses of the biology underlying fusion due to a wider availability of cellular and molecular tools. Various fusion therapies have been studied in rat models, including a range of bone graft substitute and extension materials, systemic and localized delivery of osteogenic growth factors and/or osteoporosis therapies, and stem cell transplantation therapies [4][5][6][7][8][9][10][11][12][13][14].…”
Section: Introductionmentioning
confidence: 99%